The £75 million announced in the press release relates only to the cost of reducing cancer waiting times over the spending review period. The figure is the Department's estimate of the cost to the national health service (NHS) of delivering improvements. The great majority of NHS funding is allocated to primary care trusts, who will decide spending in each area of health care in the light of both national and local priorities. The exact spend on reducing cancer waiting times in each year of the spending review period will therefore be determined locally by the NHS, and is not prescribed by the Department.